RxDoctor Payments Data

Eric Lehr, PhD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Seattle, WANPI 1265693154

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (34.5%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Atricure, Inc. at 53.2% of the total. Reporting peaked in 2024 at $22,339 and has fallen 62.2% since, to $8,447 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$71,751in general payments, 2019–2025

Across 201 payments — averaging $356.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Atricure, Inc.$38K
  • Medtronic$25K
  • Boston Scientific$2K
  • Medela AG$2K
  • Edwards Lifesciences$1K
  • Abbott$955
  • plus $3K from 7 others
$447,461in research payments, 2019–2025

Across 158 payments — averaging $2832.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$228K
  • Atricure, Inc.$115K
  • Edwards Lifesciences$105K
  • Artivion, Inc.$419

What the payments were for

  • Consulting fees$24,72534%
  • Speaking & faculty fees$13,35019%
  • Travel & lodging$24,34934%
  • Food & beverage$9,24013%
  • Education$870%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Atricure, Inc.64$38,138
Medtronic(2 entities)69$24,755
Boston Scientific14$2,431
Medela AG1$1,500
Edwards Lifesciences21$1,447
Abbott12$955
Angiodynamics, Inc.3$935
Invictus Surgical Incorporated4$840
Abiomed7$382
Arthrex3$303
Corcym Inc1$28
Baxter Healthcare1$21
Johnson & Johnson1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$71,751 in reported general payments places this provider in the 90th percentile of 105 thoracic surgery (cardiothoracic vascular surgery) providers in Washington.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Washington

Medicare billing

Part B allowed, 2024
$266,628
Medicare patients
146
Services billed
394

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Chlorhexidine Gluconate16$70

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →